By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: Fax:


Company News
Results From Merck & Co. (MRK)’s Phase 3 Study Of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir In Patients With Advanced Chronic Kidney Disease Published In Lancet 10/6/2015 12:01:00 PM
Inovio Pharma (INO) Publishes Successful Phase 2b Trial Results Of Its HPV Immunotherapy In The Lancet Lancet 9/17/2015 6:17:27 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ (tasimelteon) Phase III SET And RESET Trial Results Published In The Lancet 8/5/2015 10:44:05 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published In The Lancet 7/23/2015 8:48:29 AM
The Lancet Infectious Diseases Journal Publishes Results Of Phase II Study Of Lonafarnib In Hepatitis Delta Virus (HDV) Infected Patients 7/20/2015 7:48:28 AM
Lancet Publication Of Sham-Controlled Clinical Trial Shows Pulmonx, Inc.’s Zephyr Endobronchial Valves Deliver Significant Benefit To Emphysema Patients 7/1/2015 10:31:25 AM
Phase I Data Published in The Lancet Show Boehringer Ingelheim's Idarucizumab Reverses Anticoagulant Effects of Dabigatran 6/16/2015 8:02:06 AM
Dezima Pharma's CETP Inhibitor, TA-8995, Phase IIb (TULIP) Study Results Published In The Lancet 6/3/2015 9:03:40 AM
CSL Behring Release: Important New Findings Published In The Lancet Support The Use Of Zemaira [Alpha1-Proteinase Inhibitor (Human)] In Patients With Alpha-1 Antitrypsin Deficiency (AATD) 6/1/2015 7:46:39 AM
Merck & Co. (MRK) Announces Publication Of Pivotal Data From Phase 3 Clinical Studies Of ZERBAXA (Ceftolozane/Tazobactam) In The Lancet And Clinical Infectious Diseases 4/28/2015 10:35:12 AM